These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12508650)

  • 1. [Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug].
    Shi MG; Huang Q; Dong J; Sun ZF; Lan Q
    Ai Zheng; 2002 Oct; 21(10):1090-4. PubMed ID: 12508650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination of phenylbutyrate and 5-Aza-2'deoxycytidine inhibits human Kasumi-1 xenograft tumor growth in nude mice].
    Hao CL; Lin D; Wang LH; Xing HY; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):658-61. PubMed ID: 15634569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
    Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
    Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The experimental research of the rhBMP-2-induced apoptosis in human glioma cells].
    Zhang X; Wu J; Jing J
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):610-3. PubMed ID: 11798828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.
    Kokkinakis DM; Moschel RC; Pegg AE; Schold SC
    Clin Cancer Res; 1999 Nov; 5(11):3676-81. PubMed ID: 10589786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
    Grasso RJ; Johnson CE; Boler RK; Moore NA
    Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine, and mithramycin.
    Schold SC; Bigner DD
    Cancer Treat Rep; 1983 Sep; 67(9):811-9. PubMed ID: 6224556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.
    Branle F; Lefranc F; Camby I; Jeuken J; Geurts-Moespot A; Sprenger S; Sweep F; Kiss R; Salmon I
    Cancer; 2002 Aug; 95(3):641-55. PubMed ID: 12209758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
    Kokunai T; Kuwamura K
    No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma].
    Tang CW; Tang LP; Wang CH
    Ai Zheng; 2002 Apr; 21(4):383-7. PubMed ID: 12452016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro analysis of the cellular resistance to chemotherapeutic BCNU.
    Caballero Navarro A; Conde Guerri B; Sinues Porta E; Boada Apilluelo E; Alcalá Arellano A
    Histol Histopathol; 1992 Jul; 7(3):347-51. PubMed ID: 1504454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.